Atai stock forecast.

Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.

Some better-ranked stocks in the broader Medical space are Select Medical Holdings Corporation SEM, HCA Healthcare, Inc. HCA and Atai Life Sciences N.V. ATAI, each carrying a Zacks Rank #2 (Buy ...Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Presently, ATAI is trading below its 20W EMA, which is an extremely serious red flag. In fact, ATAI only closed above its 20W EMA once, back in late 2021. It’s just that simple to determine if the stock is or was ever a buy. Quick answer – NO! In 2020 and 2021, ATAI spent almost $60M total on R&D.

Dec 15, 2022 · What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.

1.100 USD 7 Days Forecast Get It Now! 1-Year Forecast * 0.000001 USD Historical index on US Stock Market : C "Should I invest in ATAI Life Sciences N.V. stock?" "Should I …WebATAI Life Sciences N.V. (ATAI) stock forecast and price target. Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends …WebATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...

Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.

7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.

Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. The current price was close to the IPO price in September 2020. The $21.81 stock price right now is eight percent lower than the original $23.4 price. There is still hope for recovery if the price does not plunge toward zero. The technical outlook of this stock is pretty much the same as that of Atai. Mind Medicine (MNMD)Jun 15, 2021 · Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock. Presently, ATAI is trading below its 20W EMA, which is an extremely serious red flag. In fact, ATAI only closed above its 20W EMA once, back in late 2021. It’s just that simple to determine if the stock is or was ever a buy. Quick answer – NO! In 2020 and 2021, ATAI spent almost $60M total on R&D.Apr 13, 2023 · Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ... Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. See why ATAI stock is a buy.

The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ...The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin.AI is a growth business. Total spending on AI systems is forecast to reach $97.9 billion in 2023, up from $37.5 billion in 2019. For the five-year period ending in 2023, the AI sector is predicted ...The social networking company earned $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Twitter had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 0.82%. The firm's revenue was up 37.1% compared to the same quarter last year.

Fast-forward to 2023, and the accelerating adoption of generative AI caused a rapid reversal of fortunes, and Palantir is back in investors' good graces. With a current …Web

06:48 PM ET 11/23/2020. Atai Life Sciences, a company that backs Compass Pathways ( CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the ...Aug 30, 2022 · ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ... The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.The social networking company earned $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Twitter had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 0.82%. The firm's revenue was up 37.1% compared to the same quarter last year.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...As such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors.The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CABA) forecast ROE is N/A, which is considered weak.Next reporting date. February 26, 2024. EPS forecast (this quarter) $0.34. Annual revenue (last year) $960.5M. Annual profit (last year) $40.4M. Net profit margin.Find the latest TeraWulf Inc. (WULF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...

Get the latest Mind Medicine (MindMed) Inc (MNMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.Get ATA IMS Bhd (ATAI.KL) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.ATAI Life Sciences N.V. (ATAI) stock price prediction is 6.0790759618269 USD. The ATAI Life Sciences N.V. stock forecast is 6.0790759618269 USD for 2024 November 11, Monday; and 24.831 USD for 2028 November 11, Saturday with technical analysis. ATAI Life Sciences NV ATAI Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...Find the latest CXApp Inc. (CXAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CIThese forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.Nov 18, 2022 · (See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ... 13.80 0.00 0.00% The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock …Web

ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32. Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.04: Annual revenue (last year) $0.00: Annual profit (last year)Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...Instagram:https://instagram. vertex sickle cellis robinhood or acorns betterafter hour stock gainersspab stock NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ... tsescotoreillys auto stock prices The Compass Pathways PLC stock price fell by -6.05% on the last day (Monday, 27th Nov 2023) from $6.45 to $6.06. During the last trading day the stock fluctuated 13.20% from a day low at $5.80 to a day high of $6.56. The price has risen in 6 of the last 10 days and is up by 14.99% over the past 2 weeks. Volume has increased on …ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%. lit etf stock Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...Nov 17, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...